FNCH logo

Finch Therapeutics Group, Inc. (FNCH)

Profile

Full Name

Finch Therapeutics Group, Inc.

Ticker

NASDAQ: FNCH

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 19, 2021

Indexes

Not included

Website

https://www.finchtherapeutics.com

Employees

1

Key Details

Price

$11.80(-4.84%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(-100.00% YoY)

Annual EPS

-$8.64(+81.46% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.80
    FNCH price is $11.80

    30-Day Relative Volume

    0.02
    FNCH 30-day relative volume is 0.02

    Price Performance

    Price Today change

    -4.84%
    FNCH price is down -4.84% today

    Price YTD change

    +4.42%
    FNCH price is up +4.42% since January 1st

    Price 1-year change

    +2.61%
    FNCH price is up +2.61% year-on-year

    Price 3-year change

    -84.01%
    FNCH price is down -84.01% over the past 3 years

    Price Range

    Price All-time high

    $675.00
    FNCH price is currently -98.25% below its historical high of $675.00

    Price 3-year low

    $0.80
    FNCH price is currently +1375.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $18.95M
    FNCH market capitalization is $18.95 million

    Market cap 3-year change

    -83.85%
    FNCH market capitalization is down -83.85% over the past 3 years

    Market cap All-time high

    $1.01B
    FNCH market capitalization is currently -98.11% below its historical high of $1.01 billion

    Market cap sector rank

    21.81%
    FNCH market capitalization is higher than 21.81% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    FNCH shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +1.02%
    FNCH shares outstanding is up +1.02% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.22
    FNCH beta is 0.22

    200-day SMA

    $12.85
    FNCH price is currently -8.14% below its 200-day simple moving average

    50-day SMA

    $12.55
    FNCH price is currently -5.95% below its 50-day simple moving average

    RSI

    37.00
    FNCH 14-day relative strength index is 37.00

    Volume

    0.02
    FNCH 30-day relative volume is 0.02

    ATR

    $0.39
    FNCH average true range is $0.39

    10-day Historical Volatility

    26.20%
    FNCH 10-day historical volatility is 26.20%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    FNCH annual revenue is $0.00

    Revenue Analysts estimate

    -
    FNCH annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -100%
    FNCH annual revenue is down -100% year-on-year

    Revenue Sector rank

    28.79%
    FNCH annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$8.64
    FNCH annual earnings per share is -$8.64

    EPS Analysts estimate

    -
    FNCH annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +81.46%
    FNCH annual earnings per share is up +81.46% year-on-year

    EPS Sector rank

    14.36%
    FNCH annual earnings per share is higher than 14.36% of companies in Healthcare sector

    Profit

    Gross profit

    -$174.00K
    FNCH annual gross profit is -$174.00 thousand

    Gross margin

    -
    FNCH annual gross profit margin value is unknown

    Operating profit

    -$18.86M
    FNCH annual operating income is -$18.86 million

    Operating margin

    -
    FNCH annual operating profit margin value is unknown

    Net income

    -$13.88M
    FNCH annual net profit is -$13.88 million

    Net margin

    -
    FNCH annual net profit margin value is unknown

    Expenses

    Total expenses

    $13.88M
    FNCH annual total expenses is $13.88 million

    Operating expenses

    $18.68M
    FNCH annual total operating expenses is $18.68 million

    Cost of goods sold

    $174.00K
    FNCH annual cost of goods sold is $174.00 thousand

    Selling, general & administrative expenses

    $0.00
    FNCH annual SGA is $0.00

    Depreciation and amortization

    $174.00K
    FNCH annual depreciation & amortization is $174.00 thousand

    Interest expense

    $0.00
    FNCH annual interest expense is $0.00

    Income tax

    $0.00
    FNCH annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$18.86M
    FNCH annual earnings before interest & taxes is -$18.86 million

    EBITDA

    -$18.68M
    FNCH annual EBITDA is -$18.68 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $49.75M
    FNCH annual total assets is $49.75 million

    Non current assets

    $38.98M
    FNCH annual long term assets is $38.98 million

    Current assets

    $10.77M
    FNCH annual total current assets is $10.77 million

    Cash and cash equivalents

    $10.26M
    FNCH annual cash & cash equivalents is $10.26 million

    Accounts receivable

    -
    FNCH annual accounts receivable value is unknown

    Inventory

    $0.00
    FNCH annual inventory is $0.00

    Liabilities

    Total liabilities

    $40.67M
    FNCH annual total liabilities is $40.67 million

    Long term liabilities

    $11.97M
    FNCH annual total long term liabilities is $11.97 million

    Current liabilities

    $3.17M
    FNCH annual total current liabilities is $3.17 million

    Accounts payable

    $148.00K
    FNCH annual accounts payable is $148.00 thousand

    Debt

    Total debt

    $27.79M
    FNCH annual total debt is $27.79 million

    Total debt 1-year change

    -7.75%
    FNCH annual total debt is down -7.75% year-on-year

    Long term debt

    $25.53M
    FNCH annual long term debt is $25.53 million

    Short term debt

    $2.26M
    FNCH annual short term debt is $2.26 million

    Equity & Capital

    Shareholders equity

    $9.08M
    FNCH annual stockholders equity is $9.08 million

    Book value

    $9.08M
    FNCH annual book value is $9.08 million

    Retained earnings

    -$364.27M
    FNCH annual retained earnings is -$364.27 million

    Working capital

    $7.59M
    FNCH annual working capital is $7.59 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$14.86M
    FNCH annual cash flow from operations is -$14.86 million

    Cash from operations 1-year change

    +52.83%
    FNCH annual cash flow from operations is up +52.83% year-on-year

    Cash from investing

    $0.00
    FNCH annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    -100%
    FNCH annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $0.00
    FNCH annual cash flow from financing activities is $0.00

    Cash from financing 1-year change

    +100%
    FNCH annual cash flow from financing activities is up +100% year-on-year

    CAPEX

    CAPEX

    $0.00
    FNCH annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    FNCH annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$14.86M
    FNCH annual free cash flow is -$14.86 million

    Free cash flow 1-year change

    +52.83%
    FNCH annual free cash flow is up +52.83% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    FNCH annual gross profit margin value is unknown

    Operating margin

    -
    FNCH annual operating profit margin value is unknown

    Net margin

    -
    FNCH annual net profit margin value is unknown

    ROA & ROE

    ROA

    -22.99%
    FNCH annual return on assets is -22.99%

    ROE

    -86.83%
    FNCH annual return on equity is -86.83%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    FNCH price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    FNCH price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.33
    FNCH price to book ratio is 1.33

    PB ratio Sector rank

    41.46%
    FNCH price to book ratio is higher than 41.46% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    FNCH price to sales ratio value is unknown

    PS ratio Sector rank

    -
    FNCH price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $31.90M
    FNCH enterprise value is $31.90 million

    Enterprise value Sector rank

    32.99%
    FNCH enterprise value is higher than 32.99% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.64
    FNCH EV/EBITDA is -1.64

    EV/EBITDA Sector rank

    40.18%
    FNCH EV/EBITDA is higher than 40.18% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.39
    FNCH annual current ratio is 3.39

    Quick ratio

    3.39
    FNCH annual quick ratio is 3.39

    Leverage

    Debt to equity

    3.06
    FNCH annual debt to equity ratio is 3.06

    Interest coverage ratio

    -
    FNCH annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    FNCH piotroski f-score value is unknown

    Altman Z-Score

    -11.04
    FNCH altman z-score is -11.04

    Analyst ratings

    Recent major analysts updates

    May 12, 23 HC Wainwright & Co.
    Buy
    Apr 4, 23 HC Wainwright & Co.
    Buy
    Aug 9, 22 HC Wainwright & Co.
    Buy
    Apr 4, 22 Jefferies
    Buy
    Apr 13, 21 Jefferies
    Buy
    Apr 13, 21 Evercore ISI Group
    Outperform
    Apr 13, 21 B of A Securities
    Buy

    Institutional Ownership

    Screeners with FNCH included

    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    Small cap stocks
    • What is the ticker symbol for Finch Therapeutics Group, Inc.?
    • Does Finch Therapeutics Group, Inc. pay dividends?
    • What sector is Finch Therapeutics Group, Inc. in?
    • What industry is Finch Therapeutics Group, Inc. in?
    • What country is Finch Therapeutics Group, Inc. based in?
    • When did Finch Therapeutics Group, Inc. go public?
    • Is Finch Therapeutics Group, Inc. in the S&P 500?
    • Is Finch Therapeutics Group, Inc. in the NASDAQ 100?
    • Is Finch Therapeutics Group, Inc. in the Dow Jones?
    • When was Finch Therapeutics Group, Inc.'s last earnings report?
    • When does Finch Therapeutics Group, Inc. report earnings?

    What is the ticker symbol for Finch Therapeutics Group, Inc.?

    The ticker symbol for Finch Therapeutics Group, Inc. is NASDAQ:FNCH

    Does Finch Therapeutics Group, Inc. pay dividends?

    No, Finch Therapeutics Group, Inc. does not pay dividends

    What sector is Finch Therapeutics Group, Inc. in?

    Finch Therapeutics Group, Inc. is in the Healthcare sector

    What industry is Finch Therapeutics Group, Inc. in?

    Finch Therapeutics Group, Inc. is in the Biotechnology industry

    What country is Finch Therapeutics Group, Inc. based in?

    Finch Therapeutics Group, Inc. is headquartered in United States

    When did Finch Therapeutics Group, Inc. go public?

    Finch Therapeutics Group, Inc.'s initial public offering (IPO) was on March 19, 2021

    Is Finch Therapeutics Group, Inc. in the S&P 500?

    No, Finch Therapeutics Group, Inc. is not included in the S&P 500 index

    Is Finch Therapeutics Group, Inc. in the NASDAQ 100?

    No, Finch Therapeutics Group, Inc. is not included in the NASDAQ 100 index

    Is Finch Therapeutics Group, Inc. in the Dow Jones?

    No, Finch Therapeutics Group, Inc. is not included in the Dow Jones index

    When was Finch Therapeutics Group, Inc.'s last earnings report?

    Finch Therapeutics Group, Inc.'s most recent earnings report was on May 10, 2024

    When does Finch Therapeutics Group, Inc. report earnings?

    The date for Finch Therapeutics Group, Inc.'s next earnings report has not been announced yet
    On this page